Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Covidien Announced FDA Clearance of New LigaSure(TM) Instrument

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

ARPA-H Launches IGoR Program for AI...

The Advanced Research Projects Agency for Health has officially...

Medline Launches AI-Powered Supply Chain Platform...

Medline Industries has unveiled a new artificial intelligence-driven supply...

DOJ Launches West Coast Strike Force...

The United States Department of Justice has launched a...
Febuary 17th :- Covidien, a leading global provider of healthcare products, announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LigaSure(TM) Curved, Small Jaw, Open Sealer/Divider surgical instrument. The device is indicated for use in general surgery and will be available in the United States this quarter.

The LigaSure Curved, Small Jaw, Open Sealer/Divider, the newest addition to the LigaSure family of advanced surgical cutting/sealing devices, provides an integrated cutting mechanism independent of sealing, leaving the critical cutting decisions in the hands of the surgeon. Its multi-functional design also provides for blunt dissection and an enhanced, more efficient experience for the surgeon, especially in confined surgical spaces. A primary feature of this new LigaSure device is a low-temperature profile and minimal thermal spread to surrounding tissues.

The proven LigaSure technology, powered by the ForceTriadTM energy platform, provides surgeons with a continuous output of energy, monitoring the tissue and making real-time adjustments 3,333 times/second to seal vessel walls. LigaSure technology has been in use for 12 years, and is utilized in more than one million procedures around the world each year.

MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

ARPA-H Launches IGoR Program for AI in Biomedical Research

The Advanced Research Projects Agency for Health has officially...

Medline Launches AI-Powered Supply Chain Platform in Partnership with Microsoft

Medline Industries has unveiled a new artificial intelligence-driven supply...

AI Emergency Triage Study Shows Superior Clinical Accuracy

A Harvard-led study has found that advanced artificial intelligence...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป